MF研究者総覧

教員活動データベース

Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane- and trastuzumab-naïve patients with HER2-positive, previously treated, advanced or recurrent gastric cancer (JFMC45-1102)

発表形態:
原著論文
主要業績:
主要業績
単著・共著:
共著
発表年月:
2017年
DOI:
10.1002/ijc.30383
会議属性:
指定なし
査読:
有り
リンク情報:

日本語フィールド

著者:
*Kazuhiro Nishikawa,Tsunehiro Takahashi,Hiromasa Takaishi,Akira Miki,Hirokazu Noshiro,Takaki Yoshikawa,Yasunori Nishida,Satoru Iwasa,Hiroto Miwa,Toshiki Masuishi,Narikazu Boku,Yasuhide Yamada,Yasuhiro Kodera,Kazuhiro Yoshida,Satoshi Morita,Junichi Sakamoto,Shigetoyo Saji,Yuko Kitagawa
題名:
Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane- and trastuzumab-naïve patients with HER2-positive, previously treated, advanced or recurrent gastric cancer (JFMC45-1102)
発表情報:
Int J Cancer. 巻: 140 号: 1 ページ: 188-196
キーワード:
概要:
抄録:

英語フィールド

Author:
*Kazuhiro Nishikawa,Tsunehiro Takahashi,Hiromasa Takaishi,Akira Miki,Hirokazu Noshiro,Takaki Yoshikawa,Yasunori Nishida,Satoru Iwasa,Hiroto Miwa,Toshiki Masuishi,Narikazu Boku,Yasuhide Yamada,Yasuhiro Kodera,Kazuhiro Yoshida,Satoshi Morita,Junichi Sakamoto,Shigetoyo Saji,Yuko Kitagawa
Title:
Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane- and trastuzumab-naïve patients with HER2-positive, previously treated, advanced or recurrent gastric cancer (JFMC45-1102)
Announcement information:
Int J Cancer. Vol: 140 Issue: 1 Page: 188-196


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.